Revenue
$20.62B
Fiscal year ended 2025-12-31Operating income
$2.76B
Fiscal year ended 2025-12-31Free cash flow
Unavailable
Fiscal year ended 2025-12-31GE HealthCare Technologies Inc. (GEHC) reported revenue of $20.62B and net income of $2.08B for the fiscal year ended 2025-12-31. This page shows 5 annual periods of income statement, balance sheet and cash flow figures normalized from GE HealthCare Technologies Inc.’s SEC filings, each linked to the filing it came from.
Income
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $20.62B | $19.67B | $19.55B | $18.34B | $17.58B |
| Cost of revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross profit | $8.25B | $8.20B | $7.92B | $7.18B | $7.17B |
| Operating income | $2.76B | $2.62B | $2.44B | $2.52B | $2.80B |
| Net income | $2.08B | $1.99B | $1.57B | $1.92B | $2.25B |
| Research & development | $1.26B | $1.31B | $1.20B | $1.03B | $816.00M |
| Weighted-average diluted shares | shares 458.00M | shares 459.00M | shares 458.00M | shares 454.00M | shares 454.00M |
| Pretax income | $2.77B | $2.58B | $2.36B | $2.51B | $2.88B |
| Income tax expense | $614.00M | $531.00M | $743.00M | $563.00M | $600.00M |
| Diluted EPS | $4.55 | $4.34 | $3.03 | $4.22 | $4.95 |
| Selling, general & administrative | $4.22B | $4.27B | $4.28B | $3.63B | $3.56B |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Cash & equivalents | $4.49B | $2.87B | $2.49B | $1.44B | Unavailable |
| Total assets | $36.91B | $33.09B | $32.45B | $27.54B | Unavailable |
| Current assets | $12.50B | $9.90B | $9.41B | $8.32B | Unavailable |
| Total liabilities | $26.31B | $24.44B | $25.14B | $17.95B | Unavailable |
| Current liabilities | $9.10B | $9.55B | $8.98B | $7.19B | Unavailable |
| Total equity incl. NCI | $10.39B | $8.46B | $7.14B | $9.36B | $16.68B |
| Temporary (mezzanine) equity | $209.00M | $188.00M | $165.00M | $230.00M | $220.00M |
| Inventory | $2.23B | $1.94B | $1.96B | $2.16B | Unavailable |
| Accounts receivable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Goodwill | $13.49B | $13.14B | $12.94B | $12.81B | $12.89B |
| Long-term debt | $9.50B | $7.45B | $8.44B | $8.23B | Unavailable |
| Accounts payable | $3.25B | $3.04B | $2.95B | $2.94B | Unavailable |
Cash flow
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Operating cash flow | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Capital expenditures | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Investing cash flow | -$1.05B | -$914.00M | -$558.00M | -$398.00M | -$1.76B |
| Financing cash flow | $617.00M | -$573.00M | -$478.00M | -$822.00M | -$263.00M |
| Net change in cash | $1.62B | $387.00M | $1.06B | $890.00M | -$451.00M |
| Stock-based compensation | $130.00M | $125.00M | $114.00M | $67.00M | $76.00M |
| Common dividends paid | $64.00M | $55.00M | $41.00M | $0 | $0 |
| Common share repurchases | $200.00M | $0 | $0 | Unavailable | Unavailable |
| Depreciation & amortization | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Derived
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free cash flow | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross margin | 40.0% | 41.7% | 40.5% | 39.1% | 40.8% |
| Operating margin | 13.4% | 13.3% | 12.5% | 13.8% | 15.9% |
| FCF margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| SBC / revenue | 0.6% | 0.6% | 0.6% | 0.4% | 0.4% |
| Current ratio | 1.37x | 1.04x | 1.05x | 1.16x | Unavailable |
| Revenue YoY growth | 4.8% | 0.6% | 6.6% | 4.3% | Unavailable |
| Net margin | 10.1% | 10.1% | 8.0% | 10.4% | 12.8% |
| R&D / revenue | 6.1% | 6.7% | 6.2% | 5.6% | 4.6% |
| CapEx / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Long-term debt / equity | 0.91x | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 22.2% | 20.6% | 31.5% | 22.4% | 20.9% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open GEHC in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-04-29View SEC filing
10-K · Filed 2026-02-04View SEC filing
10-Q · Filed 2025-10-29View SEC filing
10-Q · Filed 2025-07-30View SEC filing
10-Q · Filed 2025-04-30View SEC filing
10-K · Filed 2025-02-13View SEC filing
Companies in the same industry
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.